These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 29718555)

  • 1. Treatment with broadly neutralizing influenza antibodies reduces severity of secondary pneumococcal pneumonia in mice.
    van Someren Gréve F; van der Sluijs KF; Tuip AM; Schultz MJ; de Jong MD; Juffermans NP
    J Med Virol; 2018 Sep; 90(9):1431-1437. PubMed ID: 29718555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone Deacetylase Inhibition Protects Mice Against Lethal Postinfluenza Pneumococcal Infection.
    Yagi K; Ishii M; Namkoong H; Fujii H; Asami T; Suzuki S; Asakura T; Mizoguchi K; Kamo T; Tasaka S; Iwata S; Kunkel SL; Hasegawa N; Betsuyaku T
    Crit Care Med; 2016 Oct; 44(10):e980-7. PubMed ID: 27352127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Linezolid decreases susceptibility to secondary bacterial pneumonia postinfluenza infection in mice through its effects on IFN-γ.
    Breslow-Deckman JM; Mattingly CM; Birket SE; Hoskins SN; Ho TN; Garvy BA; Feola DJ
    J Immunol; 2013 Aug; 191(4):1792-9. PubMed ID: 23833238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-10 is an important mediator of the enhanced susceptibility to pneumococcal pneumonia after influenza infection.
    van der Sluijs KF; van Elden LJ; Nijhuis M; Schuurman R; Pater JM; Florquin S; Goldman M; Jansen HM; Lutter R; van der Poll T
    J Immunol; 2004 Jun; 172(12):7603-9. PubMed ID: 15187140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influenza-induced expression of indoleamine 2,3-dioxygenase enhances interleukin-10 production and bacterial outgrowth during secondary pneumococcal pneumonia.
    van der Sluijs KF; Nijhuis M; Levels JH; Florquin S; Mellor AL; Jansen HM; van der Poll T; Lutter R
    J Infect Dis; 2006 Jan; 193(2):214-22. PubMed ID: 16362885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of pro- and anti-inflammatory molecules in a mouse model of pneumococcal pneumonia after influenza.
    Smith MW; Schmidt JE; Rehg JE; Orihuela CJ; McCullers JA
    Comp Med; 2007 Feb; 57(1):82-9. PubMed ID: 17348295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary immunostimulation with MALP-2 in influenza virus-infected mice increases survival after pneumococcal superinfection.
    Reppe K; Radünzel P; Dietert K; Tschernig T; Wolff T; Hammerschmidt S; Gruber AD; Suttorp N; Witzenrath M
    Infect Immun; 2015 Dec; 83(12):4617-29. PubMed ID: 26371127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of the PI3K/AKT Signaling Pathway or Overexpression of Beclin1 Blocks Reinfection of Streptococcus pneumoniae After Infection of Influenza A Virus in Severe Community-Acquired Pneumonia.
    Yang Z; Zou X; Feng P; Zhan H; Xiong D; Lang J
    Inflammation; 2019 Oct; 42(5):1741-1753. PubMed ID: 31267272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Passive immunization against tumor necrosis factor-alpha impairs host defense during pneumococcal pneumonia in mice.
    van der Poll T; Keogh CV; Buurman WA; Lowry SF
    Am J Respir Crit Care Med; 1997 Feb; 155(2):603-8. PubMed ID: 9032201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemagglutinin Stalk- and Neuraminidase-Specific Monoclonal Antibodies Protect against Lethal H10N8 Influenza Virus Infection in Mice.
    Wohlbold TJ; Chromikova V; Tan GS; Meade P; Amanat F; Comella P; Hirsh A; Krammer F
    J Virol; 2016 Jan; 90(2):851-61. PubMed ID: 26512088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limited anti-inflammatory role for interleukin-1 receptor like 1 (ST2) in the host response to murine postinfluenza pneumococcal pneumonia.
    Blok DC; van der Sluijs KF; Florquin S; de Boer OJ; van 't Veer C; de Vos AF; van der Poll T
    PLoS One; 2013; 8(3):e58191. PubMed ID: 23483993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of the platelet-activating factor receptor in host defense against Streptococcus pneumoniae during postinfluenza pneumonia.
    van der Sluijs KF; van Elden LJ; Nijhuis M; Schuurman R; Florquin S; Shimizu T; Ishii S; Jansen HM; Lutter R; van der Poll T
    Am J Physiol Lung Cell Mol Physiol; 2006 Jan; 290(1):L194-9. PubMed ID: 16100290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preceding human metapneumovirus infection increases adherence of Streptococcus pneumoniae and severity of murine pneumococcal pneumonia.
    Lai SH; Liao SL; Wong KS; Lin TY
    J Microbiol Immunol Infect; 2016 Apr; 49(2):216-24. PubMed ID: 24931548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Premedication with Clarithromycin Is Effective against Secondary Bacterial Pneumonia during Influenza Virus Infection in a Pulmonary Emphysema Mouse Model.
    Harada T; Ishimatsu Y; Hara A; Morita T; Nakashima S; Kakugawa T; Sakamoto N; Kosai K; Izumikawa K; Yanagihara K; Mukae H; Kohno S
    J Pharmacol Exp Ther; 2016 Sep; 358(3):457-63. PubMed ID: 27489022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear factor-kappaB activation in mouse lung lavage cells in response to Streptococcus pneumoniae pulmonary infection.
    Amory-Rivier CF; Mohler J; Bédos JP; Azoulay-Dupuis E; Henin D; Muffat-Joly M; Carbon C; Moine P
    Crit Care Med; 2000 Sep; 28(9):3249-56. PubMed ID: 11008989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous peramivir inhibits viral replication, and leads to bacterial clearance and prevention of mortality during murine bacterial co-infection caused by influenza A(H1N1)pdm09 virus and Streptococcus pneumoniae.
    Onishi M; Kitano M; Taniguchi K; Homma T; Kobayashi M; Yoshinaga T; Naito A; Sato A
    Antiviral Res; 2015 May; 117():52-9. PubMed ID: 25752738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased Pulmonary Pneumococcal Clearance after Resolution of H9N2 Avian Influenza Virus Infection in Mice.
    Li J; Wang H; Lian P; Bai Y; Zhang Z; Zhao L; Xu T; Qiao J
    Infect Immun; 2021 May; 89(6):. PubMed ID: 33722928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lethal coinfection of influenza virus and Streptococcus pneumoniae lowers antibody response to influenza virus in lung and reduces numbers of germinal center B cells, T follicular helper cells, and plasma cells in mediastinal lymph Node.
    Wu Y; Tu W; Lam KT; Chow KH; Ho PL; Guan Y; Peiris JS; Lau YL
    J Virol; 2015 Feb; 89(4):2013-23. PubMed ID: 25428873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glutathione peroxidase-1 reduces influenza A virus-induced lung inflammation.
    Yatmaz S; Seow HJ; Gualano RC; Wong ZX; Stambas J; Selemidis S; Crack PJ; Bozinovski S; Anderson GP; Vlahos R
    Am J Respir Cell Mol Biol; 2013 Jan; 48(1):17-26. PubMed ID: 23002098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of severe pneumonia by hinokitiol in a murine antimicrobial-resistant pneumococcal pneumonia model.
    Isono T; Domon H; Nagai K; Maekawa T; Tamura H; Hiyoshi T; Yanagihara K; Kunitomo E; Takenaka S; Noiri Y; Terao Y
    PLoS One; 2020; 15(10):e0240329. PubMed ID: 33057343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.